IVA
Price
$2.84
Change
+$0.10 (+3.65%)
Updated
Feb 21 closing price
Capitalization
141.84M
31 days until earnings call
THAR
Price
$1.90
Change
+$0.04 (+2.15%)
Updated
Feb 21 closing price
Capitalization
3.67M
Ad is loading...

IVA vs THAR

Header iconIVA vs THAR Comparison
Open Charts IVA vs THARBanner chart's image
Inventiva SA
Price$2.84
Change+$0.10 (+3.65%)
Volume$35.41K
Capitalization141.84M
Tharimmune
Price$1.90
Change+$0.04 (+2.15%)
Volume$16.15K
Capitalization3.67M
IVA vs THAR Comparison Chart
Loading...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVA vs. THAR commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVA is a Hold and THAR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (IVA: $2.84 vs. THAR: $1.90)
Brand notoriety: IVA and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVA: 370% vs. THAR: 42%
Market capitalization -- IVA: $141.84M vs. THAR: $3.67M
IVA [@Biotechnology] is valued at $141.84M. THAR’s [@Biotechnology] market capitalization is $3.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVA’s FA Score shows that 0 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • IVA’s FA Score: 0 green, 5 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, IVA is a better buy in the long-term than THAR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVA’s TA Score shows that 5 TA indicator(s) are bullish while THAR’s TA Score has 2 bullish TA indicator(s).

  • IVA’s TA Score: 5 bullish, 4 bearish.
  • THAR’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, IVA is a better buy in the short-term than THAR.

Price Growth

IVA (@Biotechnology) experienced а +13.15% price change this week, while THAR (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

IVA is expected to report earnings on May 23, 2025.

THAR is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVA($142M) has a higher market cap than THAR($3.67M). IVA YTD gains are higher at: 32.710 vs. THAR (-6.404).
IVATHARIVA / THAR
Capitalization142M3.67M3,865%
EBITDAN/A-10.84M-
Gain YTD32.710-6.404-511%
P/E RatioN/A0.03-
RevenueN/A0-
Total CashN/A4.77M-
Total DebtN/A560K-
TECHNICAL ANALYSIS
Technical Analysis
IVATHAR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 27 days ago
83%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WPP47.47-0.15
-0.31%
WPP PLC
GNPX0.39N/A
-0.61%
Genprex
TNC86.86-2.30
-2.58%
Tennant Company
QD2.99-0.21
-6.56%
Qudian
AOUT15.65-1.19
-7.07%
American Outdoor Brands

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with INSM. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+1.99%
INSM - THAR
74%
Closely correlated
-3.05%
RAIN - THAR
52%
Loosely correlated
-0.75%
CMND - THAR
50%
Loosely correlated
+0.78%
SNGX - THAR
46%
Loosely correlated
-0.41%
AGIO - THAR
37%
Loosely correlated
+4.36%
More